ReviewFrontiers in oncology2024

Review of BCL2 inhibitors for the treatment of Waldenström's macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma.

Oliver Tomkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.